Results 191 to 200 of about 197,419 (304)

Combination of autogenous dentin graft and allograft for horizontal ridge augmentation: A case report

open access: yesClinical Advances in Periodontics, EarlyView.
Abstract Background Autogenous particulate dentin has emerged as one of the promising biocompatible alternatives to traditional bone graft materials in alveolar ridge augmentation. Although its clinical success is documented, comprehensive studies combining histological and radiographic evaluations remain limited. This case report addresses this gap by
Kosuke Kashiwagi   +4 more
wiley   +1 more source

Bone and Infections: An Osteoimmunological Interplay. [PDF]

open access: yesInt J Mol Sci
Galliera E   +5 more
europepmc   +1 more source

Subperiosteal peri‐implant augmented layer to correct bone dehiscence at immediate implant placement

open access: yesClinical Advances in Periodontics, EarlyView.
Abstract Background The purpose of the present case report is to describe the potential of the subperiosteal peri‐implant augmented layer (SPAL) technique in peri‐implant bone dehiscence (PIBD) correction at immediate implant placement (IIP). Methods This case report describes the application of the SPAL technique in two patients undergoing IIP at ...
Tommaso Grenzi   +3 more
wiley   +1 more source

Mechanosensitive ion channels as novel targets in osteoporosis. [PDF]

open access: yesJ Bone Miner Res
Beyersdorf C   +6 more
europepmc   +1 more source

Ultrafast Synthesis of a Non‐Noble FeCoNiCrZn Multi‐Element Alloy Electrocatalyst for Alkaline Oxygen Evolution Reaction

open access: yesCarbon Energy, EarlyView.
A nanoporous carbon‐coated FeCoNiCrZn multi‐element alloy on carbon cloth (FeCoNiCrZn‐C@CC) is fabricated by ultrafast pulsed laser irradiation. It has excellent OER performance, achieving an overpotential of only 233 mV at 10 mA cm−2 and remarkable stability for 94 h at 250 mA cm−2, which is due to multiple factors.
Yu Liang   +12 more
wiley   +1 more source

Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu   +5 more
wiley   +1 more source

Novel Organelle‐Based Intracellular Immunity With Mechanistic and Therapeutic Implications

open access: yesBarrier Immunity, EarlyView.
A conceptual framework illustrating how PAMPs/DAMPs initiate barrier, innate, adaptive, and intracellular immune responses, with organelle‐based intracellular immunity serving as a central integrator linking metabolism, inflammatory signaling, and therapeutic interventions to restore immune homeostasis.
Keman Xu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy